Incidence, Recurrence, Timing, and Economic Impact of Infections After CAR T-Cell Therapy: A Real-World Analysis from MarketScan Database
{{output}}
Background: Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment of hematologic malignancies but causes profound immune dysfunction and a high infections risk. Real-world data on infection incidence and econom... ...
